Hermecz I, Breining T, Mészáros Z, Kökösi J, Mészáros L, Dessy F, DeVos C
J Med Chem. 1983 Aug;26(8):1126-30. doi: 10.1021/jm00362a008.
A series of 9-hydrazono-4H-pyrido[1,2-a]pyrimidin-4-ones was prepared. The compounds were evaluated in the rat passive cutaneous anaphylaxis test for antiallergic activity. Structure-activity relationship studies revealed that the presence of a monosubstituted hydrazone moiety in position 9 and an unsubstituted 2-position are necessary for the intravenous activity.